Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2013, Article ID 580685, 6 pages
http://dx.doi.org/10.1155/2013/580685
Research Article

Low Serum Magnesium Level Is Associated with Microalbuminuria in Chinese Diabetic Patients

1Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, E-Institute of Shanghai Universities, Shanghai 200025, China
2Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Department of Endocrinology and Metabolism, Rui-Jin Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai 200025, China

Received 6 June 2013; Revised 26 July 2013; Accepted 26 July 2013

Academic Editor: Ilias Migdalis

Copyright © 2013 Baihui Xu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Xu, W. Xu, H. Yao, W. Sun, Q. Zhou, and L. Cai, “Associations of serum and urinary magnesium with the pre-diabetes, diabetes and diabetic complications in the chinese northeast population,” PLoS ONE, vol. 8, Article ID e56750, 2013. View at Google Scholar
  2. F. Guerrero-Romero and M. Rodríguez-Morán, “Low serum magnesium levels and metabolic syndrome,” Acta Diabetologica, vol. 39, no. 4, pp. 209–213, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Simmons, S. Joshi, and J. Shaw, “Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome,” Diabetes Research and Clinical Practice, vol. 87, no. 2, pp. 261–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. J. Kim, P. Xun, K. Liu et al., “Magnesium intake in relation to systemic inflammation, insulin resistance, and the incidence of diabetes,” Diabetes Care, vol. 33, no. 12, pp. 2604–2610, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. G. C. Viberti, R. J. Jarrett, and R. D. Hill, “Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus,” The Lancet, vol. 1, no. 8287, pp. 1430–1432, 1982. View at Google Scholar · View at Scopus
  6. S. F. Dinneen and H. C. Gerstein, “The association of microalbuminuria and mortality in non-insulin- dependent diabetes mellitus: a systematic overview of the literature,” Archives of Internal Medicine, vol. 157, no. 13, pp. 1413–1418, 1997. View at Google Scholar · View at Scopus
  7. A. Corsonello, R. Ientile, M. Buemi et al., “Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria,” American Journal of Nephrology, vol. 20, no. 3, pp. 187–192, 2000. View at Google Scholar · View at Scopus
  8. B. Mirrahimi, H. Hamishehkar, A. Ahmadi et al., “The efficacy of magnesium sulfate loading on microalbuminuria following SIRS: one step forward in dosing,” Daru, vol. 20, article 74, 2012. View at Google Scholar
  9. C. H. Sales, L. F. C. Pedrosa, J. G. Lima, T. M. A. M. Lemos, and C. Colli, “Influence of magnesium status and magnesium intake on the blood glucose control in patients with type 2 diabetes,” Clinical Nutrition, vol. 30, no. 3, pp. 359–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
  11. G. Eknoyan, T. Hostetter, G. L. Bakris et al., “Proteinuria and other markers of chronic kidney disease: a position statement of the National Kidney Foundation (NKF) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),” American Journal of Kidney Diseases, vol. 42, no. 4, pp. 617–622, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization, 1999.
  13. J. C. Levy, D. R. Matthews, and M. P. Hermans, “Correct homeostasis model assessment (HOMA) evaluation uses the computer program,” Diabetes Care, vol. 21, no. 12, pp. 2191–2192, 1998. View at Google Scholar · View at Scopus
  14. A. S. Levey, J. P. Bosch, J. B. Lewis, T. Greene, N. Rogers, and D. Roth, “A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation,” Annals of Internal Medicine, vol. 130, no. 6, pp. 461–470, 1999. View at Google Scholar · View at Scopus
  15. A. Allegra, A. Corsonello, M. Buemi et al., “Plasma, erythrocyte and platelet magnesium levels in type 1 diabetic patients with microalbuminuria and clinical proteinuria,” Journal of Trace Elements in Medicine and Biology, vol. 11, no. 3, pp. 154–157, 1997. View at Google Scholar · View at Scopus
  16. I. Arslanoglu, H. Gunoz, R. Bundak, and N. Saka, “Hypomagnesaemia in childhood IDDM and risk of nephropathy,” Diabetologia, vol. 38, no. 5, article 629, 1995. View at Google Scholar · View at Scopus
  17. A. H. Zargar, M. I. Bashir, S. R. Masoodi et al., “Copper, zinc and magnesium levels in type-1 diabetes mellitus,” Saudi Medical Journal, vol. 23, no. 5, pp. 539–542, 2002. View at Google Scholar · View at Scopus
  18. W. Zhang, H. Iso, T. Ohira, C. Date, and A. Tamakoshi, “Associations of dietary magnesium intake with mortality from cardiovascular disease: the JACC study,” Atherosclerosis, vol. 221, no. 2, pp. 587–595, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. H. C. Gerstein, J. F. E. Mann, Q. Yi et al., “Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals,” Journal of the American Medical Association, vol. 286, no. 4, pp. 421–426, 2001. View at Google Scholar · View at Scopus
  20. M. F. McCarty, “Magnesium may mediate the favorable impact of whole grains on insulin sensitivity by acting as a mild calcium antagonist,” Medical Hypotheses, vol. 64, no. 3, pp. 619–627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Mandon, E. Siga, D. Chabardes, D. Firsov, N. Roinel, and C. De Rouffignac, “Insulin stimulates Na+, Cl-, Ca2+, and Mg2+ transports in TAL of mouse nephron: cross-potentiation with AVP,” American Journal of Physiology, vol. 265, no. 3, pp. F361–F369, 1993. View at Google Scholar · View at Scopus
  22. C.-C. Hsu, H.-Y. Chang, M.-C. Huang et al., “Association between insulin resistance and development of microalbuminuria in type 2 diabetes: a prospective cohort study,” Diabetes Care, vol. 34, no. 4, pp. 982–987, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. N. Shao, H. Y. Kuang, N. Wang et al., “Relationship between oxidant/antioxidant markers and severity of microalbuminuria in the early stage of nephropathy in type 2 diabetic patients,” Journal of Diabetes Research, vol. 2013, Article ID 232404, 6 pages, 2013. View at Publisher · View at Google Scholar
  24. B. T. Altura and B. M. Altura, “Endothelium-dependent relaxation in coronary arteries requires magnesium ions,” British Journal of Pharmacology, vol. 91, no. 3, pp. 449–451, 1987. View at Google Scholar · View at Scopus